Dana G. Kissner

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

Crack Lung: Pulmonary Disease Caused by Cocaine Abuse

Dana G. Kissner, W. Dwayne Lawrence, James E. Selis et al. · American Review of Respiratory Disease · 1987 · 128 citations

Medicine, Clinical Sciences, Internal Medicine +15

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with <i>Pseudomonas</i> Airway Infection

Bruce C. Trapnell, Susanna A. McColley, Dana G. Kissner et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 114 citations · Full text

Pharmacy, Pharmacotherapy, Respiratory Therapy +13

Idiopathic Bronchiolitis Obliterans With Organizing Pneumonia

Imran Nizami, Dana G. Kissner, Daniel W. Visscher et al. · CHEST Journal · 1995 · 113 citations

Medicine, Clinical Sciences, Internal Medicine +8

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function

Wayne J. Morgan, Donald R. VanDevanter, David J. Pasta et al. · The Journal of Pediatrics · 2015 · 60 citations

Health Professions, Clinical Sciences, Physiology +16